BJH - volume 7, issue Abstract Book BHS, january 2016
T. Tamakloe , N. Meité , S. Amat , P. Janssens , L. Marot , J-P. Defour PhD, P. Saussoy MD, PhD, H. Poirel MD, PhD, L. Michaux MD, PhD, E. Van den Neste MD, PhD, L. Knoops MD, PhD, V. Havelange MD, PhD, C. Lambert MD, PhD, X. Poiré MD, PhD, M.C. Vekemans MD
BJH - volume 7, issue Abstract Book BHS, january 2016
S. Amat , T. Tamakloe , N. Meité , V. Havelange MD, PhD, M.C. Vekemans MD, C. Lambert MD, PhD, E. Van den Neste MD, PhD, X. Poiré MD, PhD
BJH - volume 6, issue Abstract Book BHS, january 2015
P.D.M. Katoto , N. Vanlangendonck , V. Havelange MD, PhD, X. Poiré MD, PhD, C. Lambert MD, PhD, M.C. Vekemans MD, A. Ferrant , V. Lannoy , E. Van den Neste MD, PhD
BJH - volume 6, issue Abstract Book BHS, january 2015
G. Di Prinzio , C. Cornil , E. Collinge MD, A. Devresse , P.D.M. Katoto , V. Havelange MD, PhD, E. Van den Neste MD, PhD, X. Poiré MD, PhD, M.C. Vekemans MD
BJH - volume 5, issue 3, september 2014
V. Havelange MD, PhD
Despite their small size, the impact of microRNAs in acute myeloid leukaemia seems to grow with every microRNA-related publication. Aberrant expression of microRNAs and oncogenic and tumour suppressor properties of microRNAs may contribute to the biology of acute myeloid leukaemia. As we performed for miR-29b, a critical step is to identify target genes and pathways deregulated by microRNAs during leukemogenesis. We are just starting to understand the clinical impact of microRNAs in acute myeloid leukaemia and to emphasise future microRNA-targeted therapeutic strategies. These small new actors may become important clinical contributors for the diagnosis, prognosis and treatment of acute myeloid leukaemia.
(BELG J HEMATOL 2014;5(3):110–12)
Read moreBJH - volume 5, issue Abstract Book BHS, january 2014
C. Katoto , J. De Greef , S. Bailly MD, X. Poiré MD, PhD, T. Duprez , E. Van De Neste , V. Havelange MD, PhD, L. Michaux MD, PhD, M.C. Vekemans MD
BJH - volume 5, issue Abstract Book BHS, january 2014
A. Dermine , J. Devreux , J.P. Cosyns , P. Saussoy MD, PhD, L. Labriola , M. Mourad , L. Michaux MD, PhD, X. Poiré MD, PhD, V. Havelange MD, PhD, M.C. Vekemans MD
Top
